InceptionR’s Tarsus Pharmaceuticals TARS Stock Holding History

InceptionR’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,218	Closed	-$429K	–	866
2025 Q3	$429K	Buy	+7,218	New	+$355K	0.1%	358

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

InceptionR's TARS Position: Q4 2025 in Review

InceptionR sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 7,218 shares — an estimated $429K sold.

InceptionR first reported a position in TARS in Q3 2025 and held it in 1 quarter. The position peaked at $429K in Q3 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

InceptionR reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
InceptionR sold 7,218 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $429K.
InceptionR first reported a position in Tarsus Pharmaceuticals in Q3 2025 and held it in 1 quarter.
InceptionR's Tarsus Pharmaceuticals position peaked at $429K in Q3 2025.
246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on InceptionR's 13F filing for Q4 2025, filed 11 Feb 2026.